1. CMU Intellectual Repository

Browsing by Author K. Supparatpinyo

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 10 of 10
Issue DateTitleAuthor(s)
1-Jan-2007Autochthonous visceral leishmaniasis: A report of a second case in ThailandW. Kongkaew; Potjaman Siriarayaporn; S. Leelayoova; K. Supparatpinyo; D. Areechokchai; P. Duang-ngern; K. Chanachai; T. Sukmee; Y. Samung; P. Sridurongkathum
1-Nov-2007Efficacy and tolerability of a double boosted protease inhibitor (lopinavir + saquinavir/ritonavir) regimen in HIV-infected patients who failed treatment with nonnucleoside reverse transcriptase inhibitorsP. Chetchotisakd; S. Anunnatsiri; P. Mootsikapun; S. Kiertiburanakul; T. Anekthananon; C. Bowonwatanuwong; B. Kowadisaiburana; K. Supparatpinyo; K. Ruxrungtham
1-Jan-2013Final 192-week efficacy and safety of once-daily darunavir/ritonavir compared with lopinavir/ritonavir in HIV-1-infected treatment-naïve patients in the ARTEMIS trialC. Orkin; E. Dejesus; H. Khanlou; A. Stoehr; K. Supparatpinyo; E. Lathouwers; E. Lefebvre; M. Opsomer; T. Van de Casteele; F. Tomaka
1-Sep-2012Improved neuropsychological and neurological functioning across three antiretroviral regimens in diverse resource-limited settings: Aids clinical trials group study A5199, the international neurological studyK. Robertson; H. Jiang; J. Kumwenda; K. Supparatpinyo; S. Evans; T. B. Campbell; R. Price; S. Tripathy; N. Kumarasamy; A. La Rosa; B. Santos; M. T. Silva; S. Montano; C. Kanyama; S. Faesen; R. Murphy; C. Hall; C. M. Marra; C. Marcus; B. Berzins; R. Allen; M. Housseinipour; F. Amod; I. Sanne; J. Hakim; A. Walawander; A. Nair
1-Aug-2016International neurocognitive normative study: neurocognitive comparison data in diverse resource-limited settings: AIDS Clinical Trials Group A5271K. Robertson; H. Jiang; S. R. Evans; C. M. Marra; B. Berzins; J. Hakim; N. Sacktor; M. Tulius Silva; T. B. Campbell; A. Nair; J. Schouten; With the 5271 study team; J. Kumwenda; K. Supparatpinyo; S. Tripathy; N. Kumarasamy; A. la Rosa; S. Montano; A. Mwafongo; C. Firnhaber; I. Sanne; L. Naini; F. Amod; A. Walawander
1-Apr-2010Monitoring and impact of fluconazole serum and cerebrospinal fluid concentration in HIV-associated cryptococcal meningitis-infected patientsW. Manosuthi; P. Chetchotisakd; T. L. Nolen; D. Wallace; S. Sungkanuparph; T. Anekthananon; K. Supparatpinyo; P. G. Pappas; R. A. Larsen; S. G. Filler; D. Andes
1-Mar-2021Nevirapine pharmacokinetics in HIV-infected persons receiving rifapentine and isoniazid for TB preventionA. T. Podany; J. Leon-Cruz; J. Hakim; K. Supparatpinyo; A. Omoz-Oarhe; D. Langat; N. Mwelase; C. Kanyama; A. Gupta; C. A. Benson; R. E. Chaisson; S. Swindells; C. V. Fletcher; Peter Kim; Daniel Johnson; Laura Moran; Janet Andersen; Yajing Bao; Shirley Wu; Christina Blanchard-Horan; Ann Walawander; Katherine Shin; Ruth Ebiasah; David Holland; Marc Antoine Jeanjuste; Eric Nuermberger; Sandy Pillay; Ian Sanne; Janet Nicotera; David Shugarts; Amina Shali; Jimi Tutko; Brigitte Demers; Marilyn Maroni; Jorge L. Sanchez; David Iglesias; Javier Lama; Mitch Matoga; Guilherme Do Amaral Calvet; Ronald Kibet Tonui; Taolo Modise; Margaret Kasaro; Kogieleum Naidoo; Deelip Kadam; William Burman
1-Nov-2011Predictors of poor clinical outcome of cryptococcal meningitis in HIV-infected patientsT. Anekthananon; W. Manosuthi; P. Chetchotisakd; S. Kiertiburanakul; K. Supparatpinyo; W. Ratanasuwan; P. G. Pappas; S. G. Filler; H. A. Kopetskie; T. L. Nolen; A. S. Kendrick; R. A. Larsen
1-Mar-2009Risk factors for extended-spectrum β-lactamase-producing Klebsiella pneumoniae and Escherichia coli acquisition in a tertiary care teaching hospital in ThailandR. Chaiwarith; P. Pasogpakdee; P. Salee; K. Kanjanaratanakorn; T. Sirisanthana; K. Supparatpinyo
1-Jun-2012Treatment outcomes of patients co-infected with tuberculosis and HIV at Chiang Mai university hospital, ThailandS. Limmahakhun; R. Chaiwarith; N. Nuntachit; T. Sirisanthana; K. Supparatpinyo
Showing results 1 to 10 of 10